Separation anxiety among siblings of children seeking cancer treatment in a selected tertiary care hospital, Bengaluru with a view to develop a wellness Warrior programme
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2024
Project Lead
Esther Thomas
Authors
Esther Thomas (IV B.Sc.) & Mrs. Blessy Susan, Asst. Prof.
Project Status
completed
Project Type
Student